China's WuXi Biologics will likely produce COVID-19 vaccines in Germany by the end of the year, according to local media Saturday.
The Chinese pharmaceutical company last December struck a 150-million-euro ($183.3million) deal with global chemicalsgiant Bayer to take overits drug substance manufacturing facilityin Wuppertal.
WuXi Biologics will take over the facility in a matter of a few weeks and may produce COVID-19 vaccine and active ingredients of other biological products in December after getting approval from authorities.